StockVS

Alchemy Investments Acquisition Corp 1 (ALCY) स्टॉक विश्लेषण

वित्तीय सेवाएं

Alchemy Investments Acquisition Corp 1

$11.70

+$0.05 (+0.39%)

अंतिम अपडेट: 26 मई 2026

प्राइस हिस्ट्री

विश्लेषण

कंपनी का अवलोकन

Alchemy Investments Acquisition Corp 1 (ALCY) operates primarily as a shell company with no significant ongoing business operations, intending solely to facilitate a future merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more target businesses. The company is categorized within the Financial Services sector and specifically functions in the Shell Companies industry, a classification that denotes its current status as a special purpose acquisition vehicle awaiting a definitive transaction rather than a traditional operating entity. As of the latest reporting period, the company holds a market capitalization of $50.33M, while reported annual revenue and employee count are listed as N/A, reflecting its transitional nature. These valuation figures and lack of operational scale indicate that the company's current position is defined entirely by its potential for a future business combination, meaning its value is derived from investor anticipation of a merger rather than existing cash flows or market share in a specific niche.

वित्तीय स्वास्थ्य

The company reports a Net Income of $-799,725 for the trailing twelve months, while both Revenue and EBITDA are recorded as N/A, creating a distinct financial picture where profitability exists without corresponding revenue generation in the traditional sense. The gap between the reported net loss and the unavailable revenue figures reveals a cost structure typical of SPACs, where significant expenses related to incorporation, legal fees, and administrative overhead in Newark, Del, consume capital before any operating income can be realized. Free Cash Flow stands at $-191,712, which indicates that the company is currently consuming cash reserves to fund its operations and preparatory activities rather than generating liquidity from business activities. The balance sheet shows a Cash balance of $319,258 against a Debt obligation of $1.71M, suggesting a net cash deficit position where liabilities exceed liquid assets. When analyzing the three margins—Gross Margin, Operating Margin, and Profit Margin—all are stated as 0.0%, indicating that the company has not yet achieved positive profitability from any operational activities as it awaits a merger. The Return on Equity is listed as N/A due to the nature of the equity structure, while Return on Assets is -1.6%, revealing that the company's assets are currently generating a negative return on capital employed. Regarding liquidity, the Current Ratio is 0.11, which indicates a significant shortfall in short-term assets relative to short-term liabilities, highlighting potential liquidity constraints if a transaction does not occur promptly. Although the Debt to Equity ratio is N/A, the negative 1.6% ROA and high negative free cash flow suggest that management effectiveness is currently focused on survival and deal sourcing rather than optimizing asset efficiency or generating shareholder returns.

मूल्यांकन आकलन

Trailing P/E and Forward P/E are both listed as N/A, implying that traditional earnings-based valuation multiples cannot be applied at this stage as the company has not yet generated positive earnings to support a meaningful price-to-earnings multiple. The Price to Book ratio is reported at -6.19, a negative figure that indicates the market values the company significantly below its book value, a common occurrence for shell companies that carry liabilities exceeding their tangible assets. Price to Sales and EV/EBITDA are also N/A, suggesting that these alternative valuation metrics are currently inapplicable given the lack of sales and earnings data. The stock has traded within a 52-week range defined by a high of $15.90 and a low of $10.25, with the current market price situated somewhere within this historical band, reflecting market sentiment regarding the likelihood and timing of a successful merger. The Beta value is recorded as -0.04, which is an anomalous statistic for equity securities that suggests the stock price moves inversely to the broader market or that the data reflects a specific calculation anomaly rather than standard volatility relative to the S&P 500. This negative beta implies that the stock's price behavior does not align with standard market correlation models, potentially due to its status as a non-operating shell entity with unique risk factors distinct from the broader financial services sector.

Growth & Income

Revenue Growth and Earnings Growth for the year-over-year period are both listed as N/A, indicating that the company does not have a history of growth metrics to evaluate as it has not yet entered the market with a product or service. Consequently, there is no data to determine whether earnings are growing faster or slower than revenue, as both metrics are currently undefined for this entity. The company does not pay dividends, evidenced by a Dividend Yield of N/A and a Payout Ratio of 0.0%, which means that all available capital and any future earnings upon merger will be retained by the company to fund growth initiatives or transaction costs rather than being distributed to shareholders. This reinvestment profile is typical for shell companies, where the primary objective is capital preservation until a merger deal is consummated, rather than providing regular income to investors. In summary, the overall growth and income profile for Alchemy Investments Acquisition Corp 1 is characterized by the absence of historical growth data and a complete lack of dividend distribution, focusing entirely on the strategic execution of a future business combination.

समकक्ष तुलना

Alchemy Investments Acquisition Corp 1 (ALCY) शेल कंपनियां उद्योग में कार्यरत है। बाजार पूंजीकरण के आधार पर इसके निकटतम समकक्षों से तुलना इस प्रकार है:

कंपनी टिकर मार्केट कैप P/E अनुपात
Alchemy Investments Acquisition Corp 1 ALCY $49.28M N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

शेल कंपनियां उद्योग का औसत P/E अनुपात 82.8x है। Alchemy Investments Acquisition Corp 1 का P/E अनुपात N/A है।

यह विश्लेषण AI द्वारा केवल सूचनात्मक उद्देश्यों के लिए तैयार किया गया है और यह वित्तीय सलाह नहीं है। डेटा में देरी या अशुद्धि हो सकती है। निवेश निर्णय लेने से पहले हमेशा अपना शोध करें और किसी योग्य वित्तीय सलाहकार से परामर्श लें।

Alchemy Investments Acquisition Corp 1 के बारे में

Alchemy Investments Acquisition Corp 1 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in Newark, Delaware.

कंपनी विवरण अंग्रेजी में दिखाया गया है।

वेबसाइट देखें →

मुख्य आंकड़े

मार्केट कैप
$49.28M
P/E अनुपात
N/A
52 सप्ताह उच्च
$15.90
52 सप्ताह निम्न
$10.25
औसत वॉल्यूम
2.73K
बीटा
-0.04

डेटा yfinance के माध्यम से Yahoo Finance द्वारा प्रदान किया गया है। दैनिक अपडेट।

कंपनी जानकारी

एक्सचेंज
NASDAQ
देश
United States